Evidence map›Paper›PMID 39579240›Full record

ArticleAnalytical and bioanalytical chemistry2025

Enzyme-assisted upconversion fluorescence-encoded biosensing system for simultaneous detection of multiple sites EGFR mutation.

Haiyang Gao, Gao Si, Zhendong Wang, Yanju Liu, Huaixia Yang, Mingsan Miao, Lele Ma

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haiyang Gao *Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.
Gao Si *Department of Orthopedic, Peking University Third Hospital, Beijing, 100191, China.
Zhendong WangPharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.
Yanju LiuPharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China.
Huaixia YangPharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China. yanghuaixia886@163.com.
Mingsan MiaoPharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China. miaomingsan@163.com.
Lele MaPharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, PR China. malele617@163.com.

Funding

the Postdoctoral Research Project of HenanProvince Postdoc No. 279363the Project of Tackling of Key Scientific and Technical Problems in Henan Province 192102310033,202102310149
6 · The paper itself

Abstract

Epidermal growth factor receptor (EGFR) mutations play a key role in the development of a variety of cancers. Rapid detection and screening of EGFR mutation types in patients are of great significance for early treatment of patients. In this study, a highly sensitive fluorescent biosensing system based on lanthanide ion-doped multi-type upconversion nanoparticles (UCNPs) combined with polymerization reaction signal amplification was designed and constructed for the simultaneous detection of L858R and 19Del mutations. Two upconversion nanoparticles (NaYF

Indexed as

Biosensing TechniquesErbB ReceptorsMutationFluorescenceHumansLanthanoid Series ElementsLimit of DetectionNanoparticlesSpectrometry, FluorescenceEGFR protein, humanErbB ReceptorsLanthanoid Series ElementsATRPFluorescence biosensorL858R and 19DelUpconversion nanoparticles

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.